$Monopar Therapeutics(MNPR.US)$Monopar Therapeutics Inc (MNPR–Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. AnalystSoumit Royfrom JonesTrading upgraded the rating on the stock to a Buy and gave it a $2.00 price target.
$Monopar Therapeutics(MNPR.US)$Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients 2 MINUTES AGO, 8:00 AM EDT VIA GLOBENEWSWIRE
$Monopar Therapeutics (MNPR.US)$ great I buy uvas this morning at 1.90 and shit dumps to 1.05 lowest alltime loss of 40% then I come here at 1.66 and now it dumps like wtf
Monopar Therapeutics股票討論區
🔥💯💯💯👌👌👌👌
im rich
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
暫無評論